PMID: 19900941
Would you like to forward this article to a colleague
10.3 Treatment and adjunctive management General principles include addressing comorbid symptoms (such as sleep, mood, memory, fatigue, and psychiatric disorders), emphasizing self-management tools, and employing multimodal therapies that combine several non-pharmacologic strategies
GLP-1 RA (glucagon-like peptide-1 receptor agonists) are associated with decreased cardiovascular disease, mainly driven by reduced stroke risk, and have gained interest as therapeutic agents for stroke recovery in experimental stroke models
Material that is described in commerce as "retatrutide" is therefore either (a) supplied to participants enrolled in an Eli Lilly clinical trial, (b) supplied as a chemical reference standard for laboratory research use only, or (c) sold illicitly, which has been the focus of FDA enforcement [5][6][13][14]
Generalized or disproportionate pain, hypersensitivity to light touch, burning sensations, and pain extending past a reasonable healing period are indicative of central sensitization